SXT Pharmaceuticals(US:SXTC) Jin Rong Jie·2025-08-01 14:06Core Viewpoint - Su Xuan Tang (SXTC) experienced a stock price increase of 5.13%, reaching $1.64 per share, with a total market capitalization of $19 million as of August 1 [1] Financial Performance - As of March 31, 2025, Su Xuan Tang reported total revenue of $1.7409 million, representing a year-over-year decrease of 9.73% [1] - The company's net profit attributable to shareholders was -$3.3037 million, reflecting a year-over-year decline of 6.62% [1] Company Overview - Su Xuan Tang Pharmaceutical Co., Ltd. is an innovative Chinese pharmaceutical company focused on the research, development, production, and sales of traditional Chinese medicine pieces, particularly modern Chinese medicine pieces for direct oral and infusion use [1] - Traditional Chinese medicine pieces have been widely used in China for thousands of years [1]